NUP214 and acute myeloid leukemia: 5.8. The Possible Prognostic Impact of the DEK-NUP214 Fusion for AML Patients Receiving Intensive Antileukemic Treatment: Improved Prognosis After Allogeneic Stem Cell Transplantation